Pearl River Capital, LLC Novavax Inc Transaction History

Pearl River Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $275,147 - $570,999	-7,584 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $398,995 - $817,673	5,722 Added 307.3%	7,584 $559,000
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $250,550 - $405,860	1,862 New	1,862 $266,000
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $188,034 - $400,419	-1,554 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $175,570 - $497,171	1,554 New	1,554 $282,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $175,039 - $310,108	-2,223 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $176,595 - $396,827	2,223 New	2,223 $241,000

282

84.7M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $752M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.